NCT00400296View on ClinicalTrials.gov

A Study of R547 in Patients With Advanced Solid Tumors.

PHASE1CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Neoplasms
Interventions
DRUG

RG547

Administered iv on days 1 and 8 of a 3 week cycle at escalating doses to successive groups of patients until MTD is reached.

Trial Locations (4)

28203

Charlotte

77030

Houston

80045

Aurora

08901

New Brunswick

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00400296 - A Study of R547 in Patients With Advanced Solid Tumors. | Biotech Hunter | Biotech Hunter